Continual improvement refers to the ongoing refinement of processes and practices in order to increase a company’s performance and improve the quality of its products. In the pharmaceutical industry, continual improvement is an integral part of corporate philosophy.

Conformity assessment is a procedure for checking and documenting whether products, processes or services comply with defined standards, specifications and legal requirements.

Quality parameters are quantitative characteristics that make it possible to evaluate the individual properties of a product, service or process. These parameters can be used to determine whether products, services and processes meet specified quality standards

The GMP inspection agenda is a document that describes the schedule, objectives and individual steps of a GMP inspection at a pharmaceutical manufacturing site. It is drawn up by regulatory authorities or GMP inspectorates based on the GMP guidelines.

The GMP inspectorate quality system is a cohesive unit of procedures, standards and methods for the planning, execution and evaluation of GMP inspections at pharmaceutical production sites.

A GMP inspection report is a document prepared after an inspection at a pharmaceutical manufacturing site used to evaluate compliance with GMP requirements. This report contains the results of the inspection, the deficiencies found and recommendations for corrective measures.

Risk management is a systematic process used to assess, monitor, communicate and review the risks associated with the quality of pharmaceutical products. This approach is designed to help identify potential quality risks at every step of the production cycle.

A for-cause GMP inspection is an inspection of a pharmaceutical manufacturer that takes place outside the regularly scheduled inspection plan. The purpose of a for-cause GMP inspection is to promptly review any previously identified problems identified in relation to compliance with GMP standards.

Other deficiencies are violations of the requirements of Good Manufacturing Practice (GMP) that do not directly affect the quality, safety or efficacy of the product. This category of deficiencies is considered less dramatic than critical or major deficiencies, but they must also be remedied.

Critical deficiencies are gross violations of the requirements of Good Manufacturing Practice (GMP) that have a direct impact on the quality, safety or efficacy of a drug and may pose a risk to patient health.

Side effects, or adverse drug reactions (ADRs), are undesirable reactions that can occur due to of a drug being used, even though the main purpose of any drug is to treat or prevent disease.

Infections are processes in the body that are caused by pathogens such as bacteria, viruses, fungi or parasites. These microorganisms can enter the body, multiply and cause disease by impairing the normal function of tissues or organs.

Viruses are infectious agents that can only multiply in living host cells. They attack all kinds of living organisms, from humans, plants and animals to bacteria. Viruses are generally not counted as living organisms because they cannot reproduce on their own and do not have their own metabolism.

The destruction or disposal of drugs is the process of neutralizing drugs that cannot or should not be used in order to prevent them from falling into the wrong hands or harming the environment. In many countries, the disposal of drugs is regulated by national and international laws and regulations.

The term bulk goods describes goods or materials that are bought, stored, transported or sold in large quantities without individual packaging. In the pharmaceutical industry and other sectors, it refers to the delivery of goods or raw materials that require further processing or packaging.

A pharmaceutical warehouse is a purpose-built room for the safe storage of pharmaceutical products such as drugs and medical devices. The main purpose of a pharmaceutical warehouse is to create optimal storage conditions in order to maintain product quality, efficacy and safety until delivery to the end consumer.

A GMP certificate is the colloquial name for the “Certificate of GMP Compliance of a Manufacturer.” It is issued by the competent regulatory authority and confirms that the production of a particular company complies with the standards of Good Manufacturing Practice (GMP).

A bioreactor, sometimes called a fermenter, is a device or system used to grow microorganisms or plant or animal cells under controlled conditions to produce biologically active substances such as antibiotics, proteins, enzymes and monoclonal antibodies.

In chemistry and pharmacy, intermediates are substances that are formed in intermediate stages of chemical reactions during the synthesis of the final product. These compounds can be isolated or identified during the reaction, but they are not the final product.

Cleanroom monitoring refers to the systematic inspection, measurement and recording of environmental parameters in cleanrooms to ensure compliance with specified cleanliness and contamination control standards.

Airlocks are specific anterooms or transition chambers that serve to minimize contamination at the transitions between different clean-air-controlled areas or at the entrance to cleanrooms. They are an important component of cleanroom systems.

The term “in vivo” is used to describe research, experiments or procedures carried out on living organisms such as animals, plants or humans. This allows biological processes and the effects of substances to be studied under natural conditions.

Laminar flow cabinets, also known as tissue culture hoods or laminar flow boxes, are purpose-built pieces of equipment that create a sterile working environment by generating a continuous flow of filtered air. Particles and microorganisms are absorbed by highly efficient filters.

The manufacture of animal drugs refers to the production of medicines for the treatment and prevention of diseases and the maintenance of animal health. This process includes research and development, animal studies, scale-up and quality control of the end products.

The pharmacological effect is the effect that a drug has on the human or animal body. This includes the mechanisms of action by which a drug interacts with cell structures or proteins to prevent, treat or diagnose diseases.

In Germany, pharmaceutical training encompasses a university degree followed by a practical training year that prepares students for a career in pharmacy and related fields. This training covers a wide range of topics.

Pharmaceutical waste can include chemicals and active pharmaceutical ingredients as well as various types of packaging, protective equipment, expired or spoiled drugs, laboratory reagents and other excipients.

Drug transportation is the process of transporting pharmaceutical drugs (British English: medicinal products) from the manufacturer to the wholesaler, pharmacy or hospital pharmacy, using means of transport that ensure protection against damage and loss, environmental factors and contamination.

The legal requirements for the pharmaceutical industry consist of a series of laws, guidelines, regulations and standards, compliance with which is monitored by national and international regulatory authorities in order to ensure the safety, efficacy and quality of drugs.

A contract laboratory is a specialized facility that provides scientific and analytical services on a contract basis to other organizations, primarily in the pharmaceutical, biotechnology, chemical, food and environmental industries.

Critical process parameters (CPP) are process variables that impact the critical quality attributes (CQA) and thus the safety, efficacy and quality of a drug. Therefore, these parameters must be strictly monitored.

Critical quality attributes (CQA) are physical, chemical, biological or microbiological properties of a drug that must be within certain limits or specifications in order to ensure the desired product quality.

In the context of GMP and the pharmaceutical industry, a Qualified Person (QP) is a trained individual who is responsible for ensuring that products and manufacturing processes comply with established quality and safety standards.

Drug stability is the ability of a drug to retain its original physical, chemical and microbiological properties as well as its quality, efficacy and safety under the prescribed storage conditions over a certain period of time.

An SOP (short for standard operating procedure) is a formal document that contains detailed instructions and procedures in order to ensure compliance with Good Manufacturing Practice (GMP) standards in the pharmaceutical industry.

The term systems engineering in the context of Good Manufacturing Practice (GMP) covers a wide range of systems and equipment used in pharmaceutical production to ensure efficient and safe operation in drug manufacturing.

In the context of Good Manufacturing Practice (GMP), prospective validation is the usual procedure for validation, which, in contrast to retrospective validation, is carried out before the commercial manufacture of a product begins.

Performance Qualification (PQ) is documented evidence that facilities, systems and equipment, when used together as a whole, are operating efficiently and with repeatable performance in accordance with approved requirements and process characteristics.

Installation qualification (IQ) documents that the installation of production facilities, systems and equipment has been carried out in accordance with the previously approved plan, the manufacturer’s recommendations and/or the user requirements.

Cleaning validation in pharmaceutical production confirms the effectiveness of cleaning procedures for equipment, instruments and devices used in the manufacture of drugs, vaccines or other biotechnological products.

High-throughput screening (HTS) is a comprehensive process to identify and evaluate molecules or compounds that have the potential to be used as active pharmaceutical ingredients for the treatment of certain diseases. With high-throughput screening, tens of thousands of substances can be tested automatically.

Pharmaceutical distribution is a process that encompasses all stages of the life cycle of a drug, from research and development, including clinical trials, through manufacture, quality assurance, marketing authorization, storage, distribution and sale, to pharmacovigilance.

Immunoglobulins (Ig), also known as antibodies, are protein molecules that play an important role in the human immune system. They are produced by certain types of white blood cells and fulfill a number of key functions in helping the body fight off infections.

Placebos are products that look like a drug but do not contain an active pharmaceutical ingredient. Placebos can also be therapeutic measures whereby no actual intervention is carried out. Placebos are used in clinical trials, for example, to test the efficacy of a treatment.

Biosimilars are biological drugs that are a copy of an existing biological brand-name drug. As biological drugs contain complex protein APIs whose composition is determined by the manufacturing process, they are not referred to as generic drugs.

Therapeutic equivalence is a concept used in medicine and pharmacy to compare two or more drugs to determine whether they can achieve the same therapeutic outcomes in patients under certain conditions.

The life cycle of a drug is the entirety of phases a drug undergoes from its development to its eventual withdrawal from the market. These stages cover the entire life cycle of a drug, from the initial idea to the end of its use.

ALCOA is an acronym that describes the most important principles of data integrity in a pharmaceutical quality system. It encompasses the following:

Attributable, legible, contemporaneous, original and accurate.

Computerized system validation in the pharmaceutical industry confirm and document that a computerized system (e.g. database management system, automated quality control system) performs its tasks in accordance with predefined specifications.

Drug quality is a characteristic of drug characteristic s that determines whether they meet the requirements and specifications set forth by legislators, regulatory authorities and pharmaceutical companies.

Experimental pharmacology is a branch of pharmacology that deals with research on the effects of drugs and chemical compounds on living organisms and their organs, cells and biochemical processes prior to the clinical testing of a drug.

Toxicology is an important branch of pharmacology that focuses on the study of the properties of poisons, drugs and other chemical compounds. The health risk posed by a toxic substance can be estimated based on the dose taken and the length of time it remains in the body.

Pharmacodynamics is a branch of pharmacology that studies how drugs interact at the site of action in the body and the changes resulting from the interaction. It deals with the mechanisms of action of drugs and their effects on organs and tissue.

Antibiotics are a class of active pharmaceutical ingredients used to treat infectious diseases caused by bacteria. They work by killing bacteria or slowing down the growth of bacteria so the body can fight the infection.

Technology transfer in the pharmaceutical industry is the process of transferring and implementing technical, manufacturing and operational knowledge and processes between different facilities or players in the pharmaceutical industry.

A GMP inspectorate is a unit within a state regulatory authority that is responsible for inspecting and auditing companies involved in the manufacture of drugs to ensure that they comply with Good Manufacturing Practice (GMP) standards.

A vitamin is an organic compound necessary for the maintenance of normal physiological functions in humans and animals. Vitamins are important micronutrients that the body cannot synthesize in sufficient quantities on its own and therefore must be ingested with food.

Drug labeling is the application of information and unique identification codes to drug packaging. Its purpose is to ensure the quality and safe use of drugs, prevent counterfeit products and improve their traceability.

Compulsory licenses are a mechanism that allows a state or other rights holder to grant a third party the right to manufacture, use or sell a product or technology without the consent of the rights holder and under certain conditions.

Suppositories are a dosage form that consist of small solid cones or cylinders for insertion into body cavities in order to achieve a systemic or local effect using an active pharmaceutical ingredient. Suppositories are usually administered as rectal or vaginal suppositories.

Tablets are a form of single-dose drugs intended for peroral administration. Tablets are solid disks or pressed shapes that are usually produced by mixing the active pharmaceutical ingredient with excipients and pressing them in special machines called tablet presses.

Pharmaceutical biology is the field of pharmacy that deals with the development, manufacture and application of biologics. In contrast to chemical drugs, biopharmaceuticals use living organisms or their components to treat and prevent diseases.

A Site Master File (SMF) in pharmaceutical manufacture is a document that contains information on and descriptions of a pharmaceutical production site and its facilities. It is created and maintained by the pharmaceutical company.

Cross-contamination refers to the transfer of microorganisms, chemicals or particles from one substance, object, surface or environment to another, which can lead to unwanted contamination or pollution.

Sterility is a state or condition in which an object, area, surface, liquid, medical instrument or other item is completely free of living microorganisms such as bacteria, viruses, fungi and protozoa.

Stem cells are a special type of cell with the unique ability to self-renew and differentiate into different types of specialized cells in the body. They play an important role in development, growth, tissue regeneration and organ repair in the body.

PIC/S is an acronym for Pharmaceutical Inspection Co-operation Scheme. PIC/S is an international association of GMP regulatory authorities. PIC/S is intended to help improve cooperation between regulatory authorities and the pharmaceutical industry in the area of GMP.

A vaccine is a biological drug used to stimulate the body’s immune system in order to prevent disease. Vaccines for active immunization contain antigens that can trigger an immune response without causing disease.

Pharmaceutical equipment includes a wide range of technical devices and machines used in the pharmaceutical industry for the production, packaging and quality control of drugs, medical devices and other health-related products.

Good Storage Practice (GSP) refers to a set of standards and rules designed to ensure that products such as drugs, medical devices and foodstuffs are stored safely, efficiently and in a way that preserves their quality.

Good Automated Manufacturing Practice (GAMP) is a set of standards and guidelines designed to ensure the safety, reliability and quality of automated systems and processes across a variety of industries, including the pharmaceutical industry.

Good Pharmacovigilance Practice (GVP) is a set of standards, strategies and procedures designed to monitor, evaluate and document the safety of drugs after they have been placed on the market and once patients have started taking them.

Good Distribution Practice (GDP) is a system of standards and principles designed to ensure the efficacy and quality of drugs and medical devices during the process of distribution and logistics.

Good Manufacturing Practice (GMP) is a system of guidelines and regulations for the manufacture of drugs, medical devices, diagnostics, food, food additives and active pharmaceutical ingredients.

Preclinical research refers to experimental studies that are carried out before the start of clinical trials on humans. They are the first stage in the development and evaluation of new medical technologies, active pharmaceutical ingredients, medical devices and treatments.

Drug efficacy is a measure of how successfully and effectively a drug achieves the desired effect in treating, preventing or controlling a patient’s disease or condition. Efficacy is usually determined based on clinical trials.

Reference standards are substances that are used to test the quality of active pharmaceutical ingredients using physical, chemical and biological analytical methods in order to confirm the compliance of the active pharmaceutical ingredients with the requirements of the documentation drawn up during the marketing authorization process.

Brand-name drugs, also known as brand-name medicines, are drugs that have been developed and approved by the original pharmaceutical company. This company is the developer of the new active pharmaceutical ingredient or the new dosage form and therefore also the patent holder.

Dietary supplements are categorized as foods for general consumption. However, they are taken as capsules or effervescent tablets, for example, and in much smaller quantities than food in the narrower sense. They contain vitamins, minerals and other nutrients.

Drug development is a complex process toward creating a new drug that includes the search for new active pharmaceutical ingredients, the subsequent investigation of their properties, preclinical research and the development of technologies for manufacture.

Orphan drugs (or orphan medicines) are drugs that are developed for the diagnosis, prevention or treatment of rare diseases (also known as orphan diseases).

The manufacture of drugs in accordance with Good Manufacturing Practice is a systematic process designed to achieve a high level of quality, safety and efficacy. Compliance with GMP guidelines creates a certain level of trust in drugs based on strict standards and requirements.

Herbal raw materials can be used to obtain powders or extracts, for example, which are then used to produce capsules and other dosage forms. Herbal drugs can be found in allopathy, including highly potent APIs such as paclitaxel, a cytostatic substance.

Pharmacovigilance serves to monitor the safety and efficacy of drugs after their market launch. It includes monitoring adverse drug reactions (side effects and interactions) and the evaluation of the data obtained in order to take action if necessary.

The dosage form determines how a drug interacts with the body, how it is absorbed and how it fulfills its function. According to GMP guidelines, every dosage form must be designed, manufactured and prepared in accordance with strict regulations in order to guarantee its quality, safety and efficacy.

The validation of pharmaceutical production is a systematic review and documentation process that ensures that all manufacturing processes, equipment and systems in the production of drugs function predictably, reliably and in accordance with established standards and specifications.

A pharmaceutical quality system consists of a set of procedures, standards, practices and resources that a pharmaceutical company implements and maintains to ensure a high level of quality in its products.